Severe respiratory insufficiency causes patients to be intolerant of physical effort and to be frequently limited in their daily activity and results in an imbalance between food intake and nutritional needs. Undernutrition and overnutrition can both affect the quality of life and survival of patients with pulmonary disease. Protein-energy malnutrition can lead to quantitative, qualitative and functional alterations of muscle [1,2] and this affects muscle function, including respiratory muscle in patients with already limited respiratory reserves. Optimal adaptation of nutrition support through the assessment of fat-free mass (FFM) and fat mass (FM) in patients with chronic respiratory insufficiency can avoid or minimize muscle wasting or obesity. For these reasons, the nutritional assessment should include body composition measurements which are based on objective rather than subjective criteria of nutritional evaluation. Body composition can be measured by a number of techniques, including hydrodensitometry, isotope dilution, and whole-body counting of potassium-40 [3]. However, these methods are not easily applicable in ill subjects.More recent methods for the determination of the FFM are dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA). DXA has been validated against independent methods, including a gamma neutronactivation model [4,5], total body potassium and hydrodensitometry [6] and is becoming one of the reference methods for body composition analysis, but requires sophisticated technology. BIA is a method of measuring body composition which is easy, noninvasive and inexpensive [7]. BIA measurements have been validated in healthy adults [8][9][10]. The relationship between body impedance and body composition is dependent on age and sex [11,12]. Over 20 different formulae permit the calculation of the FFM and FM based on BIA measurements and have generally been validated in healthy, young adults. SCHOLS et al. [13] proposed a BIA formula validated against deuterium dilution for patients with chronic obstructive pulmonary disease (COPD) (n=24), which included weight and height 2 /resistance (ht 2 /R) as independent variables. Recently, PICHARD et al. [14] were unable to obtain clinically relevant correlations between FFM calculated by 12 BIA formulae [8,9,11,[15][16][17][18][19][20][21], including SCHOLS et al. [13], and DXA-determined FFM, and suggested that a specific formula should be developed for patients with chronic severe respiratory insufficiency. These results suggest that the bioelectrical impedance analysis formula specific to patients with severe respiratory insufficiency give a better correlation and smaller mean differences than 12 different bioelectrical impedance analysis formulae described in the medical literature. A prediction equation, validated against dual-energy X-ray absorptiometry and based on subjects with similar clinical characteristics, is more applicable to the patients with respiratory insufficiency than a formula developed for healthy subje...